AVANOS MEDICAL, INC.
No enriched coverage for $AVNS in the last 7 days.
AVANOS MEDICAL, INC. (AVNS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 4 avnsform8k_07272026xex101.htm EX-10.1 Document Execution Version CREDIT AGREEMENT dated as of July 27, 2026 among A-AV MERGERSUB, INC., as the Initial Borrower, AVANOS MEDICAL, INC., as the Borrower Representative, A-AV ACQUIRECO, INC., as a Borrower, A-AV INTERMEDIATEC
AIP completed a take-private buyout of Avanos Medical. Under the deal terms, Avanos stockholders receive $25 per share in cash for each share of common stock they hold. The transaction removes Avanos from public trading, affecting shareholders and any related trading activity.
Delgado Sigfrido (SVP, Operations) sold (to issuer) 110,627 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($2.77M total) across 2 trades on 2026-07-27.
Recent AVNS coverage spans insider activity and mergers & acquisitions.
In the last 30 days, AVNS insiders filed 12 SEC Form 4 transactions — no purchases and 12 sales ($33.8M). The most active reporter was Delgado Sigfrido, SVP, Operations, with 2 filings.
The filing signals a completed asset transaction and associated financing documentation, which can change leverage, cash needs, and risk profile.
Cash-out at $25 per share makes the equity effectively a completed exit, reducing near-term trading uncertainty but ending upside participation.
This is a routine insider transaction (sale to issuer) with no stated 10b5-1 plan, but it does not by itself signal a fundamental change.
This is a disclosed insider sale to the issuer (buyback participation style), not an open-market sale; it is unlikely to change fundamentals but can affect near-term sentiment.
This is a large, same-day insider sale to the issuer (buyback participation), with no remaining direct holdings reported.
alphai scores every news story that mentions AVNS with an AI model for sentiment and relevance, and aggregates insider trades from AVANOS MEDICAL, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
AVANOS MEDICAL, INC. (AVNS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 4 avnsform8k_07272026xex101.htm EX-10.1 Document Execution Version CREDIT AGREEMENT dated as of July 27, 2026 among A-AV MERGERSUB, INC., as the Initial Borrower, AVANOS MEDICAL, INC., as the Borrower Representative, A-AV ACQUIRECO, INC., as a Borrower, A-AV INTERMEDIATEC
2 min readAIP completed a take-private buyout of Avanos Medical. Under the deal terms, Avanos stockholders receive $25 per share in cash for each share of common stock they hold. The transaction removes Avanos from public trading, affecting shareholders and any related trading activity.
1 min readDelgado Sigfrido (SVP, Operations) sold (to issuer) 110,627 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($2.77M total) across 2 trades on 2026-07-27.
2 min readGalovan Scott Michael (SVP, Chief Financial Officer) sold (to issuer) 231,717 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($5.79M total) across 2 trades on 2026-07-27.
1 min readPacitti David (Chief Executive Officer) sold (to issuer) 766,924 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($19.17M total) across 2 trades on 2026-07-27.
1 min readShimer Julie Ann sold (to issuer) 50,090 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.25M total) on 2026-07-27.
2 min readOLEARY PATRICK J sold (to issuer) 54,640 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.37M total) on 2026-07-27.
1 min readFranchini Indrani Lall sold (to issuer) 4,817 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($0.12M total) on 2026-07-27.
1 min readEgbuonu-Davis Lisa sold (to issuer) 13,811 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($0.35M total) on 2026-07-27.
1 min readBLACKFORD GARY sold (to issuer) 79,590 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.99M total) on 2026-07-27.
1 min read
